Furthermore, this study identified previously unreported alterations in the FGFR3 gene and chromosome regions 19p13.3, 8p23.1 and 1p36.32; thus highlighting novel mutations of MM that warrant further investigation in terms of their suitability as diagnostic and/or treatment response monitoring biomarkers of MM (73). The gene discussed is FGFR3; the disease is Miyoshi myopathy.